News1 month ago
AstraZeneca’s Asthma Drug Fails in ‘Smoker’s Lung’ Study
AstraZeneca (AZN.L) announced on Wednesday that its asthma treatment, Fasenra, failed to meet its primary goal in a late-stage trial for patients with chronic obstructive pulmonary...